2011
DOI: 10.3892/ijo.2011.1035
|View full text |Cite
|
Sign up to set email alerts
|

Molecular targets of selenium in prostate cancer prevention (Review)

Abstract: Abstract. Prostate cancer is one of the leading causes of cancer-related deaths among males. Although use of the micronutrient selenium in prostate cancer clinical trials is limited, the outcomes indicate that selenium is a promising treatment. Furthermore, selenium inhibits prostate cancer through multiple mechanisms, and it is beneficial in controlling the development of this disease. This review highlights the latest epidemiological and biomolecular research on selenium in prostate cancer, as well as its pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 73 publications
0
5
0
Order By: Relevance
“…However, there is a wealth of preclinical data demonstrating that different chemical forms of Se have different effects. In cultured prostate cancer cells, different Se compounds target different molecular mechanisms to inhibit proliferation and viability (15,16). In rodent models of prostate cancer, various Se species likewise show varying degrees of efficacy (reviewed in ref.…”
mentioning
confidence: 99%
“…However, there is a wealth of preclinical data demonstrating that different chemical forms of Se have different effects. In cultured prostate cancer cells, different Se compounds target different molecular mechanisms to inhibit proliferation and viability (15,16). In rodent models of prostate cancer, various Se species likewise show varying degrees of efficacy (reviewed in ref.…”
mentioning
confidence: 99%
“…[10] Briefl y, cells (2 × 10 4 in 50 l/well) were plated in 96-well plates. After the initial cell seeding, different concentrations of each extract were added and incubated for 24 h. Ten microliters of water-soluble tetrazolium (WST)-8 assay cell-counting solution (Dojindo Lab., Tokyo, Japan) was added to each well and incubated at 37°C for 3 h. After the addition of 100 l/well of 1 NHCl, the cell proliferation rate was then determined by measuring the absorbance at a wavelength of 450 nm, with a reference wavelength of 650 nm.…”
Section: Drug Sensitivity Assaymentioning
confidence: 99%
“…Se induces cellular apoptosis, presumably by acting on the functions of many intracellular proteins important for these apoptotic cascades. In addition, depending on the form, Se compounds can target separate pathways and the existence of diverse responses for the same chemical structure suggest several mechanisms of action and targets [79]. In an experiment comparing the apoptotic mechanisms of the Se compounds MeSeCys, SeMet and sodium selenite in four cell lines from human oral squamous cell carcinoma (HSC-3 and HSC-4), human non-small cell lung adenocarcinoma (A549) and human breast cancer (MCF-7), showed a different response based on the both the compound and the cell line used.…”
Section: Apoptosis and Miscellaneous Mechanisms And Structuresmentioning
confidence: 99%